In the present study, we discovered that miR-708-3p is downregulated in patients with IPF and that miR-708-3p can target ADAM17 through the GATA/STAT3 signal pathway to control IPF initiation and progression. Here, QRSL1 is linked to idiopathic pulmonary fibrosis.